Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered?

被引:13
|
作者
Thatrimontrichai, Anucha [1 ]
Apisarnthanarak, Anucha [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Dept Pediat, Div Neonatol, Hat Yai, Thailand
[2] Thammasat Univ Hosp, Dept Med, Div Infect Dis, Pathum Thani 12120, Thailand
关键词
Active surveillance; Asymptomatic infections; Gram-negative bacteria; Infection control; Multidrug resistance; INTENSIVE-CARE UNITS; ACINETOBACTER-BAUMANNII COLONIZATION; SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; INFECTION; OUTBREAK; PREVENTION; BACTERIA; ENTEROBACTERIACEAE;
D O I
10.1016/j.jfma.2019.08.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing burden of multidrug-resistant gram-negative bacilli (MDR-GNB) infection has highlighted the urgent requirement for efficient prevention and control strategies. A routine active surveillance culture (ASC) program of asymptomatic carriers as part of an infection prevention strategy for MDR-GNB still has some controversy. An ASC program for colonized patients may be beneficial depending on the targeted population, level of endemicity, the species of pathogen, and the combination of multifaceted strategies. Multimodal infection control and prevention strategies are crucial for implementation in resources-limited settings. After discovering the culprit, it is a challenge to control MDR-GNB by containment or eradication and prevent cross-transmission. An ASC program should consider both the local epidemiology and cost-effectiveness based on the available resources in endemic MDR-GNB areas in the Asia-Pacific region. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:1581 / 1585
页数:5
相关论文
共 50 条
  • [1] Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms
    Yuan, Zhe
    Tam, Vincent H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (05) : 661 - 668
  • [2] Genomic epidemiology of multidrug-resistant Gram-negative organisms
    Hawken, Shawn E.
    Snitkin, Evan S.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1435 (01) : 39 - 56
  • [3] What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
    Harris, Anthony D.
    McGregor, Jessina C.
    Furuno, Jon P.
    CLINICAL INFECTIOUS DISEASES, 2006, 43 : S57 - S61
  • [4] Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit
    Abbott, Iain J.
    Jenney, Adam W. J.
    Spelman, Denis W.
    Pilcher, David V.
    Sidjabat, Hanna E.
    Richardson, Leisha J.
    Paterson, David L.
    Peleg, Anton Y.
    PATHOLOGY, 2015, 47 (06) : 575 - 579
  • [5] Acquisition of Multidrug-Resistant Gram-Negative Organisms During Travel
    Murray, Clinton K.
    Blyth, Maj Dana M.
    MILITARY MEDICINE, 2017, 182 (9-10) : 26 - 33
  • [6] Surveillance culture for multidrug-resistant gram-negative bacteria: Performance in liver transplant recipients
    Freire, Maristela Pinheiro
    Villela Soares Oshiro, Isabel Cristina
    Bonazzi, Patricia Rodrigues
    Pierrotti, Ligia Camera
    de Oliveira, Larissa Marques
    Machado, Anna Silva
    Van Der Heijdenn, Inneke Marie
    Rossi, Flavia
    Costa, Silvia Figueiredo
    Carneiro D'Albuquerque, Luiz Augusto
    Abdala, Edson
    AMERICAN JOURNAL OF INFECTION CONTROL, 2017, 45 (03) : E40 - E44
  • [7] Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
    Janet Y. Wu
    Pavithra Srinivas
    Jason M. Pogue
    Infectious Diseases and Therapy, 2020, 9 : 17 - 40
  • [8] Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms
    Glasser, Jessie S.
    Markelz, Ana E.
    Zera, Wendy C.
    Beckius, Miriam L.
    Mende, Katrin
    Murray, Clinton K.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 649 - 651
  • [9] New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
    Shio-Shin Jean
    Ian M. Gould
    Wen-Sen Lee
    Po-Ren Hsueh
    Drugs, 2019, 79 : 705 - 714
  • [10] New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
    Jean, Shio-Shin
    Gould, Ian M.
    Lee, Wen-Sen
    Hsueh, Po-Ren
    DRUGS, 2019, 79 (07) : 705 - 714